Advanced search
Publication Cover
Molecular and Cellular Biology Volume 24, 2004 - Issue 22
Submit an article Journal homepage
156
Views
87
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Mechanism of B-Cell Receptor-Induced Phosphorylation and Activation of Phospholipase C-γ2

Yeun Ju Kim1 Laboratory of Cell Signaling, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland;2 Center for Cell Signaling Research and Division of Molecular Life Sciences, Ewha Womans University, Seoul, South Korea
,
Fujio Sekiya1 Laboratory of Cell Signaling, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
,
Benoit Poulin1 Laboratory of Cell Signaling, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
,
Yun Soo Bae2 Center for Cell Signaling Research and Division of Molecular Life Sciences, Ewha Womans University, Seoul, South Korea
&
Sue Goo Rhee1 Laboratory of Cell Signaling, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MarylandCorrespondence[email protected]
Pages 9986-9999 | Received 24 Feb 2004, Accepted 17 Aug 2004, Published online: 27 Mar 2023

Citations (87)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Osmond J D’Cruz & Fatih M Uckun. (2013) Novel Bruton’s tyrosine kinase inhibitors currently in development. OncoTargets and Therapy 6, pages 161-176.
Read now
Kumudha Balakrishnan & Varsha Gandhi. (2012) Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia. Expert Opinion on Investigational Drugs 21:4, pages 409-423.
Read now
Fatih M Uckun & Sanjive Qazi. (2010) Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity. Expert Opinion on Therapeutic Patents 20:11, pages 1457-1470.
Read now
Fatih M. Uckun. (2008) Clinical Potential of Targeting Bruton's Tyrosine Kinase. International Reviews of Immunology 27:1-2, pages 43-69.
Read now

Articles from other publishers (83)

Yaqiang Cao, Shuai Liu, Kairong Cui, Qingsong Tang & Keji Zhao. (2023) Hi-TrAC detects active sub-TADs and reveals internal organizations of super-enhancers. Nucleic Acids Research.
Crossref
Elisabeth Mulazzani, Klara Kong, Juan I. Aróstegui, Ashley P. Ng, Nishika Ranathunga, Waruni Abeysekera, Alexandra L. Garnham, Sze-Ling Ng, Paul J. Baker, Jacob T. Jackson, John D. Lich, Margaret L. Hibbs, Ian P. Wicks, Cynthia Louis & Seth L. Masters. (2023) G-CSF drives autoinflammation in APLAID. Nature Immunology 24:5, pages 814-826.
Crossref
Ryohei Kozaki, Tomoko Yasuhiro, Hikaru Kato, Jun Murai, Shingo Hotta, Yuko Ariza, Shunsuke Sakai, Ryu Fujikawa & Takao Yoshida. (2023) Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective Bruton’s tyrosine kinase inhibitor, by phosphoproteomics and transcriptomics. PLOS ONE 18:3, pages e0282166.
Crossref
Jing Li, FeiMing Huang, QingLan Ma, Wei Guo, KaiYan Feng, Tao Huang & Yu-Dong Cai. (2023) Identification of genes related to immune enhancement caused by heterologous ChAdOx1–BNT162b2 vaccines in lymphocytes at single-cell resolution with machine learning methods. Frontiers in Immunology 14.
Crossref
Qi Peng, Dong Luo, Yi Yang, Yinghua Zhu, Qingming Luo, Huan Chen, Dapeng Chen, Zhongjun Zhou & Xiaomei Lu. (2023) Clinical and immunological features of an APLAID patient caused by a novel mutation in PLCG2. Frontiers in Immunology 14.
Crossref
Aqu Alu, Hong Lei, Xuejiao Han, Yuquan Wei & Xiawei Wei. (2022) BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies. Journal of Hematology & Oncology 15:1.
Crossref
Weam Othman Elbezanti, Omar S. Al-Odat, Robert Chitren, Jaikee Kumar Singh, Sandeep Kumar Srivastava, Krishne Gowda, Shantu Amin, Gavin P. Robertson, Venkatesh V. Nemmara, Subash C. Jonnalagadda, Tulin Budak-Alpdogan & Manoj K. Pandey. (2022) Development of a novel Bruton’s tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells. Frontiers in Pharmacology 13.
Crossref
Ke Li, Beibei Ran, Yu Wang, Lulu Liu & Weidong Li. (2022) PLCγ2 impacts microglia-related effectors revealing variants and pathways important in Alzheimer’s disease. Frontiers in Cell and Developmental Biology 10.
Crossref
Rachael Arthur, Alexander Wathen, Elizabeth A. Lemm, Freda K. Stevenson, Francesco Forconi, Adam J. Linley, Andrew J. Steele, Graham Packham & Beatriz Valle-Argos. (2022) BTK-independent regulation of calcium signalling downstream of the B-cell receptor in malignant B-cells. Cellular Signalling 96, pages 110358.
Crossref
Baskar Ramdas, Lisa Deng Yuen, Lakshmi Reddy Palam, Roshini Patel, Santhosh Kumar Pasupuleti, Victoria Jideonwo, Ji Zhang, Callista Maguire, Eric Wong, Rahul Kanumuri, Chujing Zhang, George Sandusky, Rebecca J. Chan, Chi Zhang, Elliot Stieglitz, Laura Haneline & Reuben Kapur. (2022) Inhibition of BTK and PI3Kδ impairs the development of human JMML stem and progenitor cells. Molecular Therapy 30:7, pages 2505-2521.
Crossref
Annika C. Betzler, Sebastian Kieser, Katja Fiedler, Simon Laban, Marie-Nicole Theodoraki, Patrick J. Schuler, Thomas Wirth, Kerry Tedford, Klaus-Dieter Fischer, Thomas K. Hoffmann & Cornelia Brunner. (2022) Differential Requirement of Vav Proteins for Btk-dependent and –Independent Signaling During B Cell Development. Frontiers in Cell and Developmental Biology 10.
Crossref
Lindsay E. Nyhoff, Amber S. Griffith, Emily S. Clark, James W. Thomas, Wasif N. Khan & Peggy L. Kendall. (2021) Btk Supports Autoreactive B Cell Development and Protects against Apoptosis but Is Expendable for Antigen Presentation. The Journal of Immunology 207:12, pages 2922-2932.
Crossref
Jacob T. Jackson, Elisabeth Mulazzani, Stephen L. Nutt & Seth L. Masters. (2021) The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration. Journal of Biological Chemistry 297:2, pages 100905.
Crossref
Eris Bame, Hao Tang, Jeremy C Burns, Million Arefayene, Klaus Michelsen, Bin Ma, Isaac Marx, Robin Prince, Allie M Roach, Urjana Poreci, Douglas Donaldson, Patrick Cullen, Fergal Casey, Jing Zhu, Thomas M Carlile, Dipen Sangurdekar, Baohong Zhang, Patrick Trapa, Joseph Santoro, Param Muragan, Alex Pellerin, Stephen Rubino, Davide Gianni, Bekim Bajrami, Xiaomei Peng, Alex Coppell, Katherine Riester, Shibeshih Belachew, Devangi Mehta, Mike Palte, Brian T Hopkins, Matthew Scaramozza, Nathalie Franchimont & Michael Mingueneau. (2021) Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells. Clinical & Translational Immunology 10:6.
Crossref
Megan Noble, Qi-Tong Lin, Christian Sirko, Jacob A. Houpt, Matthew J. Novello & Peter B. Stathopulos. (2020) Structural Mechanisms of Store-Operated and Mitochondrial Calcium Regulation: Initiation Points for Drug Discovery. International Journal of Molecular Sciences 21:10, pages 3642.
Crossref
Li Wang, Wei Qin, Yu-Jia Huo, Xiao Li, Qing Shi, John E. J. Rasko, Anne Janin & Wei-Li Zhao. (2020) Advances in targeted therapy for malignant lymphoma. Signal Transduction and Targeted Therapy 5:1.
Crossref
Limor Parker, Hilla Bahat, Michael Y. Appel, Dina Volodarsky Baum, Relly Forer, Nir Pillar, Michael Goldberg & Michael Goldman. (2018) Phospholipase C-Gamma 2 Activity in Familial Steroid-Sensitive Nephrotic Syndrome. Pediatric Research 85:5, pages 719-723.
Crossref
Jingwen Li, Wei Yin, Yukai Jing, Danqing Kang, Lu Yang, Jiali Cheng, Ze Yu, Zican Peng, Xingbo Li, Yue Wen, Xizi Sun, Boxu Ren & Chaohong Liu. (2019) The Coordination Between B Cell Receptor Signaling and the Actin Cytoskeleton During B Cell Activation. Frontiers in Immunology 9.
Crossref
Christoph B. Geier, Kai M. T. Sauerwein, Alexander Leiss-Piller, Isabella Zmek, Michael B. Fischer, Martha M. Eibl & Hermann M. Wolf. (2018) Hypomorphic Mutations in the BCR Signalosome Lead to Selective Immunoglobulin M Deficiency and Impaired B-cell Homeostasis. Frontiers in Immunology 9.
Crossref
Simar Pal Singh, Floris Dammeijer & Rudi W. Hendriks. (2018) Role of Bruton’s tyrosine kinase in B cells and malignancies. Molecular Cancer 17:1.
Crossref
Claudia Walliser, Martin Wist, Elisabeth Hermkes, Yuan Zhou, Anja Schade, Jennifer Haas, Julia Deinzer, Laurent Désiré, Shawn S.C. Li, Stephan Stilgenbauer, Joshua D. Milner & Peter Gierschik. (2018) Functional characterization of phospholipase C-γ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder. Oncotarget 9:76, pages 34357-34378.
Crossref
Andrea Franco, Zachary Kraus, Huifang Li, Naomi Seibert, Jessica Dement-Brown & Mate Tolnay. (2018) CD21 and FCRL5 form a receptor complex with robust B-cell activating capacity. International Immunology.
Crossref
Zhen Zhang, Daoguang Zhang, Yang Liu, Dezhi Yang, Fansheng Ran, Michael L. Wang & Guisen Zhao. (2018) Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors. Archiv der Pharmazie 351:7, pages 1700369.
Crossref
Alexander P. ByeAmanda J. UnsworthMichael J. DesboroughCatherine A. T. Hildyard, Niamh Appleby, David Bruce, Neline KriekSophie H. NockTanya SageCraig E. HughesJonathan M. Gibbins. (2017) Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib. Blood Advances 1:26, pages 2610-2623.
Crossref
Manoj K. Pandey, Krishne Gowda, Shen-shu Sung, Thomas Abraham, Tulin Budak-Alpdogan, Giampolo Talamo, Sinisa Dovat & Shantu Amin. (2017) A novel dual inhibitor of microtubule and Bruton's tyrosine kinase inhibits survival of multiple myeloma and osteoclastogenesis. Experimental Hematology 53, pages 31-42.
Crossref
John W. Cuozzo, Paolo A. Centrella, Diana Gikunju, Sevan Habeshian, Christopher D. Hupp, Anthony D. Keefe, Eric A. Sigel, Holly H. Soutter, Heather A. Thomson, Ying Zhang & Matthew A. Clark. (2017) Discovery of a Potent BTK Inhibitor with a Novel Binding Mode by Using Parallel Selections with a DNA-Encoded Chemical Library. ChemBioChem 18:9, pages 864-871.
Crossref
Uri Rozovski, David M. Harris, Ping Li, Zhiming Liu, Preetesh Jain, Ivo Veletic, Alessandra Ferrajoli, Jan Burger, Susan O'Brien, Prithviraj Bose, Philip Thompson, Nitin Jain, William Wierda, Michael J. Keating & Zeev Estrov. (2017) Constitutive Phosphorylation of STAT3 by the CK2–BLNK–CD5 Complex. Molecular Cancer Research 15:5, pages 610-618.
Crossref
Wei Du, Rebecca Goldstein, Yanwen Jiang, Omar Aly, Leandro Cerchietti, Ari Melnick & Olivier Elemento. (2017) Effective Combination Therapies for B-cell Lymphoma Predicted by a Virtual Disease Model. Cancer Research 77:8, pages 1818-1830.
Crossref
Samer Halabi, Eiki Sekine, Brett Verstak, Nicholas J. Gay & Martin C. Moncrieffe. (2017) Structure of the Toll/Interleukin-1 Receptor (TIR) Domain of the B-cell Adaptor That Links Phosphoinositide Metabolism with the Negative Regulation of the Toll-like Receptor (TLR) Signalosome. Journal of Biological Chemistry 292:2, pages 652-660.
Crossref
Yingying Zuo & Zhengying Pan. 2018. Cancer II. Cancer II 75 104 .
John C Allen, Fatima Talab & Joseph R Slupsky. (2016) Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?. International Journal of Hematologic Oncology 5:1, pages 37-53.
Crossref
Kim R. Simpfendorfer, Brandon E. Armstead, Andrew Shih, Wentian Li, Mark Curran, Nataly Manjarrez-Orduño, Annette T. Lee, Betty Diamond & Peter K. Gregersen. (2015) Autoimmune Disease-Associated Haplotypes of BLK Exhibit Lowered Thresholds for B Cell Activation and Expansion of Ig Class-Switched B Cells . Arthritis & Rheumatology 67:11, pages 2866-2876.
Crossref
Heide Christine PattersonCarolin GerbethPrathapan ThiruNora F. VögtleMarko KnollAliakbar ShahsafaeiKaitlin E. SamochaCher X. HuangMark Michael HardenRui SongCynthia ChenJennifer KaoJiahai ShiWendy SalmonYoav D. ShaulMatthew P. StokesJeffrey C. SilvaGeorge W. BellDaniel G. MacArthurJürgen RulandChris MeisingerHarvey F. Lodish. (2015) A respiratory chain controlled signal transduction cascade in the mitochondrial intermembrane space mediates hydrogen peroxide signaling. Proceedings of the National Academy of Sciences 112:42.
Crossref
Preetesh Jain & Susan O'Brien. 2015. Targeted Therapy in Translational Cancer Research. Targeted Therapy in Translational Cancer Research 130 144 .
M Spaargaren, M F M de Rooij, A P Kater & E Eldering. (2014) BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future. Oncogene 34:19, pages 2426-2436.
Crossref
Michael Reth, Lars Nitschke, Masaki Hikida & Tomohiro Kurosaki. 2015. Molecular Biology of B Cells. Molecular Biology of B Cells 151 170 .
Odilia B. J. Corneth, Roel G. J. Klein Wolterink & Rudi W. Hendriks. 2016. B Cell Receptor Signaling. B Cell Receptor Signaling 67 105 .
Yuichi Tokuda, Masami Tanaka, Tomohito Yagi & Kei Tashiro. (2014) The defect of SFRP2 modulates an influx of extracellular calcium in B lymphocytes. BMC Research Notes 7:1.
Crossref
Yiming Zhong, John C. Byrd & Jason A. Dubovsky. (2014) The B-Cell Receptor Pathway: A Critical Component of Healthy and Malignant Immune Biology. Seminars in Hematology 51:3, pages 206-218.
Crossref
Rudi W. Hendriks, Saravanan Yuvaraj & Laurens P. Kil. (2014) Targeting Bruton's tyrosine kinase in B cell malignancies. Nature Reviews Cancer 14:4, pages 219-232.
Crossref
Joseph R. Slupsky. (2014) Does B Cell Receptor Signaling in Chronic Lymphocytic Leukaemia Cells Differ from That in Other B Cell Types?. Scientifica 2014, pages 1-14.
Crossref
Wasif N. Khan, Jacqueline A. Wright, Eden Kleiman, Justin C. Boucher, Iris Castro & Emily S. Clark. (2013) B-lymphocyte tolerance and effector function in immunity and autoimmunity. Immunologic Research 57:1-3, pages 335-353.
Crossref
Tamas Balla. (2013) Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation. Physiological Reviews 93:3, pages 1019-1137.
Crossref
Marta Pires de Miranda, Filipa B. Lopes, Colin E. McVey, Xosé R. Bustelo & J. Pedro Simas. (2013) Role of Src Homology Domain Binding in Signaling Complexes Assembled by the Murid γ-Herpesvirus M2 Protein. Journal of Biological Chemistry 288:6, pages 3858-3870.
Crossref
Francina Deason-Towne, Anne-Laure Perraud & Carsten Schmitz. (2012) Identification of Ser/Thr phosphorylation sites in the C2-domain of phospholipase C γ2 (PLCγ2) using TRPM7-kinase. Cellular Signalling 24:11, pages 2070-2075.
Crossref
Guoping Fu, Yuhong Chen, James Schuman, Demin Wang & Renren Wen. (2012) Phospholipase Cγ2 Plays a Role in TCR Signal Transduction and T Cell Selection. The Journal of Immunology 189:5, pages 2326-2332.
Crossref
Christine Le RoyPierre-Antoine Deglesne, Nathalie Chevallier, Taoufik Beitar, Virginie Eclache, Maude QuettierMarouane Boubaya, Rémi Letestu, Vincent Lévy, Florence Ajchenbaum-Cymbalista & Nadine Varin-Blank. (2012) The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia. Blood 120:2, pages 356-365.
Crossref
Claudio Raimondi, Anissa Chikh, Tania Maffucci & Marco Falasca. (2012) A novel regulatory mechanism links PLCγ1 to PDK1. Journal of Cell Science.
Crossref
Claudio Raimondi & Marco Falasca. (2012) Phosphoinositides signalling in cancer: Focus on PI3K and PLC. Advances in Biological Regulation 52:1, pages 166-182.
Crossref
Aurelie Gresset, John Sondek & T. Kendall Harden. 2012. Phosphoinositides I: Enzymes of Synthesis and Degradation. Phosphoinositides I: Enzymes of Synthesis and Degradation 61 94 .
Donald MacGlashanJr.Jr., Lee A. Honigberg, Ashley Smith, Joseph Buggy & John T. Schroeder. (2011) Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton's tyrosine kinase, Btk, inhibitor. International Immunopharmacology 11:4, pages 475-479.
Crossref
Julie A Di Paolo, Tao Huang, Mercedesz Balazs, James Barbosa, Kai H Barck, Brandon J Bravo, Richard A D Carano, James Darrow, Douglas R Davies, Laura E DeForge, Lauri Diehl, Ronald Ferrando, Steven L Gallion, Anthony M Giannetti, Peter Gribling, Vincent Hurez, Sarah G Hymowitz, Randall Jones, Jeffrey E Kropf, Wyne P Lee, Patricia M Maciejewski, Scott A Mitchell, Hong Rong, Bart L Staker, J Andrew Whitney, Sherry Yeh, Wendy B Young, Christine Yu, Juan Zhang, Karin Reif & Kevin S Currie. (2010) Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis. Nature Chemical Biology 7:1, pages 41-50.
Crossref
Naoki Kajiwara, Tomomi Sasaki, Peter Bradding, Glenn Cruse, Hironori Sagara, Kazumitsu Ohmori, Hirohisa Saito, Chisei Ra & Yoshimichi Okayama. (2010) Activation of human mast cells through the platelet-activating factor receptor. Journal of Allergy and Clinical Immunology 125:5, pages 1137-1145.e6.
Crossref
Taku Kambayashi, David F. LaRosa, Michael A. Silverman & Gary A. Koretzky. (2009) Cooperation of adapter molecules in proximal signaling cascades during allergic inflammation. Immunological Reviews 232:1, pages 99-114.
Crossref
Robert L. Geahlen. (2009) Syk and pTyr'd: Signaling through the B cell antigen receptor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1793:7, pages 1115-1127.
Crossref
Tomohiro Kurosaki & Masaki Hikida. (2009) Tyrosine kinases and their substrates in B lymphocytes. Immunological Reviews 228:1, pages 132-148.
Crossref
Ian K. Townley, Erin Schuyler, Michelle Parker-Gür & Kathy R. Foltz. (2009) Expression of multiple Src family kinases in sea urchin eggs and their function in Ca2+ release at fertilization. Developmental Biology 327:2, pages 465-477.
Crossref
Andrew C. Vendel, Jill Calemine-Fenaux, Anita Izrael-Tomasevic, Vandana Chauhan, David Arnott & Dan L. Eaton. (2009) B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK. The Journal of Immunology 182:3, pages 1509-1517.
Crossref
Wasif N. Khan, Nicholas P. Shinners, Iris Castro & Kristen L. Hoek. 2010. BLyS Ligands and Receptors. BLyS Ligands and Receptors 19 41 .
Claudia Walliser, Michael Retlich, Richard Harris, Katy L. Everett, Michelle B. Josephs, Petra Vatter, Diego Esposito, Paul C. Driscoll, Matilda Katan, Peter Gierschik & Tom D. Bunney. (2008) Rac Regulates Its Effector Phospholipase Cγ2 through Interaction with a Split Pleckstrin Homology Domain. Journal of Biological Chemistry 283:44, pages 30351-30362.
Crossref
Michele Weber, Bebhinn Treanor, David Depoil, Hisaaki Shinohara, Naomi E. Harwood, Masaki Hikida, Tomohiro Kurosaki & Facundo D. Batista. (2008) Phospholipase C-γ2 and Vav cooperate within signaling microclusters to propagate B cell spreading in response to membrane-bound antigen. Journal of Experimental Medicine 205:4, pages 853-868.
Crossref
Hye Sun Kuehn, Michael A. Beaven, Hong-Tao Ma, Mi-Sun Kim, Dean D. Metcalfe & Alasdair M. Gilfillan. (2008) Synergistic activation of phospholipases Cγ and Cβ: A novel mechanism for PI3K-independent enhancement of FcεRI-induced mast cell mediator release. Cellular Signalling 20:4, pages 625-636.
Crossref
Csaba Ortutay, Beston F. Nore, Mauno Vihinen & C.I. Edvard Smith. 2008. 51 80 .
Lulu Cao, Kebing Yu, Cindy Banh, Vinh Nguyen, Anna Ritz, Benjamin J. Raphael, Yuko Kawakami, Toshiaki Kawakami & Arthur R. Salomon. (2007) Quantitative Time-Resolved Phosphoproteomic Analysis of Mast Cell Signaling. The Journal of Immunology 179:9, pages 5864-5876.
Crossref
Michael J. McCabeJrJr, Michael D. Laiosa, Li Li, Sherri L. Menard, Raymond R. Mattingly & Allen J. Rosenspire. (2007) Low and Nontoxic Inorganic Mercury Burdens Attenuate BCR-Mediated Signal Transduction. Toxicological Sciences 99:2, pages 512-521.
Crossref
Nicholas P. Shinners, Gianluca Carlesso, Iris Castro, Kristen L. Hoek, Radiah A. Corn, Robert L. Woodland, Martin L. Scott, Demin Wang & Wasif N. Khan. (2007) Bruton’s Tyrosine Kinase Mediates NF-κB Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R Family. The Journal of Immunology 179:6, pages 3872-3880.
Crossref
Joo Hyun Nam, Hoo-Se Lee, Yen Hoang Nguyen, Tong Mook Kang, Sung Won Lee, Hye-Young Kim, Sang Jeong Kim, Yung E. Earm & Sung Joon Kim. (2007) Mechanosensitive activation of K + channel via phospholipase C-induced depletion of phosphatidylinositol 4,5-bisphosphate in B lymphocytes . The Journal of Physiology 582:3, pages 977-990.
Crossref
T. MaffucciM. Falasca. (2007) Phosphoinositide 3-kinase-dependent regulation of phospholipase Cγ. Biochemical Society Transactions 35:2, pages 229-230.
Crossref
Taku Kambayashi & Gary A. Koretzky. (2007) Proximal signaling events in FcɛRI-mediated mast cell activation. Journal of Allergy and Clinical Immunology 119:3, pages 544-552.
Crossref
Björn Stork, Konstantin Neumann, Ingo Goldbeck, Sebastian Alers, Thilo Kähne, Michael Naumann, Michael Engelke & Jürgen Wienands. (2007) Subcellular localization of Grb2 by the adaptor protein Dok-3 restricts the intensity of Ca2+ signaling in B cells. The EMBO Journal 26:4, pages 1140-1149.
Crossref
Simon T. Abrams, Tasneem Lakum, Ke Lin, Gemma M. Jones, Andrew T. Treweeke, Mosavar Farahani, Mair Hughes, Mirko Zuzel & Joseph R. Slupsky. (2006) B-cell receptor signaling in chronic lymphocytic leukemia cells is regulated by overexpressed active protein kinase CβII. Blood 109:3, pages 1193-1201.
Crossref
P.G. QUINTER, C.A. DANGELMAIER, T.M. QUINTON, S.P. KUNAPULI & J.L. DANIEL. (2007) Glycoprotein VI agonists have distinct dependences on the lipid raft environment. Journal of Thrombosis and Haemostasis 5:2, pages 362-368.
Crossref
Fatih M. Uckun, Ilker Dibirdik, Sanjive Qazi, Alexei Vassilev, Hong Ma, Chen Mao, Alexey Benyumov & Katayoon H. Emami. (2007) Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK). Bioorganic & Medicinal Chemistry 15:2, pages 800-814.
Crossref
Kristen L. Hoek, Pierre Antony, John Lowe, Nicholas Shinners, Bhaskarjyoti Sarmah, Susan R. Wente, Demin Wang, Rachel M. Gerstein & Wasif N. Khan. (2006) Transitional B Cell Fate Is Associated with Developmental Stage-Specific Regulation of Diacylglycerol and Calcium Signaling upon B Cell Receptor Engagement. The Journal of Immunology 177:8, pages 5405-5413.
Crossref
C.R. Shideman, S. Hu, P.K. Peterson & S.A. Thayer. (2006) CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism. Journal of Neuroscience Research 83:8, pages 1471-1484.
Crossref
Kenichiro Matsuo, Hitoshi Hotokezaka, Naoya Ohara, Yuji Fujimura, Atsutoshi Yoshimura, Yukio Okada, Yoshitaka Hara, Noriaki Yoshida & Koji Nakayama. (2006) Analysis of Amphotericin B-Induced Cell Signaling with Chemical Inhibitors of Signaling Molecules. Microbiology and Immunology 50:4, pages 337-347.
Crossref
Yen-Yu Lin, Chien-Fu Hung & T.-C. Wu. (2006) Functional Studies of Lymphocytes Using RNAi Technology. Transfusion Medicine and Hemotherapy 33:1, pages 80-88.
Crossref
Thomas Piechulek, Tobias Rehlen, Claudia Walliser, Petra Vatter, Barbara Moepps & Peter Gierschik. (2005) Isozyme-specific Stimulation of Phospholipase C-γ2 by Rac GTPases. Journal of Biological Chemistry 280:47, pages 38923-38931.
Crossref
Qun Yi, Katsue Suzuki-Inoue, Naoki Asazuma, Osamu Inoue, Steve P. Watson & Yukio Ozaki. (2005) Docking protein Gab2 positively regulates glycoprotein VI-mediated platelet activation. Biochemical and Biophysical Research Communications 337:2, pages 446-451.
Crossref
S.P. WATSON, J.M. AUGER, O.J.T. McCARTY & A.C. PEARCE. (2005) GPVI and integrin αIIbβ3 signaling in platelets. Journal of Thrombosis and Haemostasis 3:8, pages 1752-1762.
Crossref
Pedro R. Cutillas, Barbara Geering, Mike D. Waterfield & Bart Vanhaesebroeck. (2005) Quantification of Gel-separated Proteins and Their Phosphorylation Sites by LC-MS Using Unlabeled Internal Standards. Molecular & Cellular Proteomics 4:8, pages 1038-1051.
Crossref
Benoit Poulin, Fujio Sekiya & Sue Goo Rhee. (2005) Intramolecular interaction between phosphorylated tyrosine-783 and the C-terminal Src homology 2 domain activates phospholipase C-γ1. Proceedings of the National Academy of Sciences 102:12, pages 4276-4281.
Crossref
Masaki Hikida & Tomohiro Kurosaki. 2005. 73 96 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.